Hassabis is also the CEO of Isomorphic Labs, which is applying these advancements to the field of drug discovery. The preclinical phase of drug development has traditionally relied on traditional ...

But now, in collaboration with several leading international pharmaceutical companies, Standigm is focusing on the earliest stages of drug discovery, with the identification of useful novel ...

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

The total time from target discovery to the start of phase 1 took under 30 months and cost only a fraction of a conventional drug discovery program. Insilico was founded in 2014 by a team of ...